157 related articles for article (PubMed ID: 34432316)
1. Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.
Jawad MU; Bayne CO; Farhan S; Haffner MR; Carr-Ascher J; Alvarez E; Thorpe SW; Randall RL
J Surg Oncol; 2021 Dec; 124(8):1515-1522. PubMed ID: 34432316
[TBL] [Abstract][Full Text] [Related]
2. Primary mobile vertebral column sarcomas: Prognostic factors vary by histologic subtypes.
Jawad MU; Farhan S; Haffner MR; Le HV; Thorpe SW; Klineberg EO; Randall RL
J Surg Oncol; 2021 Sep; 124(4):635-645. PubMed ID: 34091907
[TBL] [Abstract][Full Text] [Related]
3. Malignant neoplasms originating from the bones of the foot: Predilection of hematological malignancies and sex-related and ethnic disparities in amputation.
Jawad MU; Farhan SB; Haffner MR; Kreulen CD; Giza E; Thorpe SW; Randall RL
J Surg Oncol; 2021 Dec; 124(8):1468-1476. PubMed ID: 34351631
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of sarcomas occurring in bone and joint: A SEER based study.
Zhou H; He S; Zhang D; Wang J; Yang X; Jiao J; Xu W; Yang J; Xiao J
Medicine (Baltimore); 2023 Oct; 102(43):e34231. PubMed ID: 37904412
[TBL] [Abstract][Full Text] [Related]
5. Pediatric head and neck bone sarcomas: An analysis of 204 cases.
Brady JS; Chung SY; Marchiano E; Eloy JA; Baredes S; Park RCW
Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():71-76. PubMed ID: 28802390
[TBL] [Abstract][Full Text] [Related]
6. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
[TBL] [Abstract][Full Text] [Related]
7. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
8. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
[TBL] [Abstract][Full Text] [Related]
9. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
Smartt AA; Jang ES; Tyler WK
Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
[TBL] [Abstract][Full Text] [Related]
10. Racial and ethnic disparities in treatment and survival of pediatric sarcoma.
Jacobs AJ; Lindholm EB; Levy CF; Fish JD; Glick RD
J Surg Res; 2017 Nov; 219():43-49. PubMed ID: 29078908
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
Lee RJ; Arshi A; Schwartz HC; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
14. Demographic determinants of survival in osteosarcoma.
Nathan SS; Healey JH
Ann Acad Med Singap; 2012 Sep; 41(9):390-9. PubMed ID: 23052433
[TBL] [Abstract][Full Text] [Related]
15. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
16. Surgery significantly improves survival in patients with chordoma.
Jawad MU; Scully SP
Spine (Phila Pa 1976); 2010 Jan; 35(1):117-23. PubMed ID: 20042964
[TBL] [Abstract][Full Text] [Related]
17. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
18. Overview of sarcomas in the adolescent and young adult population.
Herzog CE
J Pediatr Hematol Oncol; 2005 Apr; 27(4):215-8. PubMed ID: 15838394
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors in Patients With Osteosarcoma With the Surveillance, Epidemiology, and End Results Database.
Fu P; Shi Y; Chen G; Fan Y; Gu Y; Gao Z
Technol Cancer Res Treat; 2020; 19():1533033820947701. PubMed ID: 32787692
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma as a second malignant neoplasm.
Hamre MR; Severson RK; Chuba P; Lucas DR; Thomas RL; Mott MP
Radiother Oncol; 2002 Dec; 65(3):153-7. PubMed ID: 12464443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
